Skip to:

"J&J Vaccine Pause Won’t Affect California Reopening"

The Associated Press interviewed Dr. Timothy Brewer, UCLA Fielding School of Public Health professor of epidemiology, about whether California’s pause on using the Johnson & Johnson vaccine as federal agencies examine a rare side effect is likely to affect vaccination efforts

Share: 
Date: 
Tuesday, April 13, 2021
Contact: 

California’s pause on using the Johnson & Johnson vaccine as federal agencies examine a possible and rare side effect is unlikely to affect vaccination efforts in the nation’s most populous state as it moves to start inoculating people 16 and older this week.

State officials directed counties and other providers on Tuesday to halt use of the vaccine per federal recommendation. But Gov. Gavin Newsom said he does not expect the halt to “materially impact our ability to fulfill our expectations.” Vaccinations are expected to be available for people 16 and older Thursday and California plans to lift most pandemic restrictions in mid-June.

Newsom said the Johnson & Johnson vaccine accounts for only 4% of the state’s current supply and that inoculations of more than 3 million people a week will keep the state on track to reopen broadly June 15. He said officials are working to switch about 8,800 people who had made Johnson & Johnson reservations via a state online platform to Pfizer and Moderna shots.

READ MORE